CAS NO: | 51-48-9 |
包装 | 价格(元) |
10mM (in 1mL DMSO) | 电议 |
500mg | 电议 |
1g | 电议 |
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 776.87 |
Cas No. | 51-48-9 |
Formula | C15H11I4NO4 |
Solubility | ≥27.35 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH |
Chemical Name | (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid |
Canonical SMILES | IC(C=C(C=C1I)C[C@@H](C(O)=O)N)=C1OC(C=C2I)=CC(I)=C2O |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
Animal experiment:[1] | |
Animal models | Weanling mice of the Swiss-Webster strain |
Dosage form | 0.9 or 2.7 μg Administered subcutaneously 2 hours before the administration of purified porcine thyrotropin-releasing factor (TRF) |
Applications | L-Thyroxine inhibited synthesis and release of thyrotropin (TSH) induced by TRF from the anterior pituitary in mice. Complete inhibition of the TRF-TSH release response was achieved with 2.7 μg L-thyroxine and partial inhibition occurred with 0.9 μg L-thyroxine. The inhibition caused by L-thyroxine could be overcame by increasing the dose of TRF. |
Note | The technical data provided above is for reference only. |
References: 1. Bowers CY, Schally AV, Reynolds GA, et al. Interactions of L-thyroxine or L-triiodothyronine and thyrotropin-releasing factor on the release and synthesis of thyrotropin from the anterior pituitary gland of mice. Endocrinology, 1967, 81(4): 741-747. |